Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT
Titel:
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT
Auteur:
Boers-Sonderen, Marye J. Geus-Oei, Lioe-Fee de Desar, Ingrid M. E. Graaf, Winette T. A. van der Oyen, Wim J. G. Ottevanger, Petronella B. Herpen, Carla M. L. van